Publication:
Mesenchymal stromal cells derived from the bone marrow of acute lymphoblastic leukemia patients show altered BMP4 production: correlations with the course of disease

dc.contributor.authorVicente López, Ángeles
dc.contributor.authorVázquez García, Miriam Nohemí
dc.contributor.authorMelen, Gustavo J
dc.contributor.authorEntrena Martínez, Ana
dc.contributor.authorRamírez Orellana, Manuel
dc.contributor.authorZapata González, Agustín Gregorio
dc.contributor.authorCubillo, Isabel
dc.contributor.authorGarcia-Castro, Javier
dc.contributor.funderMinisterio de Ciencia e Innovación (España)
dc.contributor.funderAsociación Española Contra el Cáncer
dc.contributor.funderComunidad de Madrid (España)
dc.contributor.funderInstituto de Salud Carlos III
dc.contributor.funderMinisterio de Educación, Cultura y Deporte (España)
dc.date.accessioned2020-07-07T20:16:56Z
dc.date.available2020-07-07T20:16:56Z
dc.date.issued2014
dc.description.abstractThe relevance of tumor microenvironment for the development and progression of tumor cells in hematological malignancies has been extensively reported. Identification of factors involved in the information exchange between the malignant cells and the bone marrow mesenchymal stem cells (BM-MSCs) and the knowledge on their functioning may provide important information to eliminate leukemic cells from protective BM niches. We evaluated changes in BM-MSCs obtained from children with acute lymphoblastic leukemia (ALL) at different times in the course of disease. Whereas ALL-MSCs did not exhibit phenotypic changes compared to BM-derived MSCs isolated from healthy donors, they exhibited increased adipogenic capacity. In addition, the viability of healthy CD34+ hematopoietic progenitors was significantly reduced when co-cultured with ALL-MSCs. ALL-MSCs grow less efficiently, although gradually recover normal growth with treatment. Accordingly, proliferation is particularly low in MSCs obtained at diagnosis and in the first days of treatment (+15 days), recovering to control levels after 35 days of treatment. Correlating these results with bone morphogenetic protein 4 (BMP4) production, a molecule demonstrated to affect MSC biology, we found higher production of BMP4 in ALL-MSCs derived from patients over the course of disease but not in those free of leukemia. However, no significant differences in the expression of different members of the BMP4 signaling pathway were observed. Furthermore, an inverse correlation between high levels of BMP4 production in the cultures and MSC proliferation was found, as observed in MSCs derived from patients at diagnosis that produce high BMP4 levels. In addition, co-culturing ALL-MSC with the REH leukemia cell line, but not CD34+ hematopoietic progenitors, powerfully enhanced BMP4 production, suggesting an intimate crosstalk among ALL-MSCs isolated from BM colonized by ALL cells that presumably also occurs in situ conditions. Our data may support the participation of BMP4 in BM niche, but the mechanism remains to be elucidated.es_ES
dc.description.peerreviewedes_ES
dc.description.sponsorshipThis work was supported by grands BFU2009-10315, SAF2012-33180, and BFU2010-18250 from the Spanish Ministry of Science and Innovation, Spanish Association Against Cancer 2010 AECC; P2010/BMD-2420-CellCAM from Regional Government of Madrid and RD12/0019/0007-TerCell Network from the Health Institute Carlos III. MNVG contract UCM number 50053735 by Comunidad de Madrid. AE grant number AP2010-0795 of Ministry of Education, Culture and Sports. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.es_ES
dc.format.number1es_ES
dc.format.pagee84496es_ES
dc.format.volume9es_ES
dc.identifier.citationPLoS One . 2014 Jan 6;9(1):e84496es_ES
dc.identifier.doi10.1371/journal.pone.0084496es_ES
dc.identifier.e-issn1932-6203es_ES
dc.identifier.journalPloS onees_ES
dc.identifier.pubmedID24400095es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/10695
dc.language.isoenges_ES
dc.publisherPublic Library of Science (PLOS)
dc.relation.projectIDinfo:eu_repo/grantAgreement/ES/BFU2009-10315es_ES
dc.relation.projectIDinfo:eu_repo/grantAgreement/ES/SAF2012-33180es_ES
dc.relation.projectIDinfo:eu_repo/grantAgreement/ES/BFU2010-18250es_ES
dc.relation.projectIDinfo:eu_repo/grantAgreement/ES/P2010/BMD-2420-CellCAMes_ES
dc.relation.projectIDinfo:eu_repo/grantAgreement/ES/RD12/0019/0007es_ES
dc.relation.projectIDinfo:eu_repo/grantAgreement/ES/50053735es_ES
dc.relation.projectIDinfo:eu_repo/grantAgreement/ES/AP2010-0795es_ES
dc.relation.publisherversionhttps://doi.org/10.1371/journal.pone.0084496es_ES
dc.repisalud.centroISCIII::Instituto de Investigación de Enfermedades Rarases_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subject.meshAdolescentes_ES
dc.subject.meshAntigens, CD34es_ES
dc.subject.meshBone Morphogenetic Protein 4es_ES
dc.subject.meshCell Differentiationes_ES
dc.subject.meshCell Line, Tumores_ES
dc.subject.meshCell Proliferationes_ES
dc.subject.meshCell Survivales_ES
dc.subject.meshChildes_ES
dc.subject.meshChild, Preschooles_ES
dc.subject.meshCoculture Techniqueses_ES
dc.subject.meshDisease Progressiones_ES
dc.subject.meshFemalees_ES
dc.subject.meshHematopoietic Stem Cellses_ES
dc.subject.meshHumanses_ES
dc.subject.meshImmunophenotypinges_ES
dc.subject.meshInfantes_ES
dc.subject.meshMalees_ES
dc.subject.meshMesenchymal Stem Cellses_ES
dc.subject.meshNeoplasm Staginges_ES
dc.subject.meshNeoplastic Stem Cellses_ES
dc.subject.meshPhenotypees_ES
dc.subject.meshPrecursor Cell Lymphoblastic Leukemia-Lymphomaes_ES
dc.subject.meshSignal Transductiones_ES
dc.titleMesenchymal stromal cells derived from the bone marrow of acute lymphoblastic leukemia patients show altered BMP4 production: correlations with the course of diseasees_ES
dc.typeresearch articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublicationc5bf1e5e-fe9a-417c-b23f-a60d6661df90
relation.isAuthorOfPublication4a9c54ab-2eb3-4c6c-b68d-d21cc6e81869
relation.isAuthorOfPublication.latestForDiscoveryc5bf1e5e-fe9a-417c-b23f-a60d6661df90
relation.isFunderOfPublication289dce42-6a28-4892-b0a8-c70c46cbb185
relation.isFunderOfPublication453a1189-9bca-4be8-8d60-695f50fe028b
relation.isFunderOfPublicationc87c70a3-e023-4b6b-ac25-1b2d1b483786
relation.isFunderOfPublication7d739953-4b68-4675-b5bb-387a9ab74b66
relation.isFunderOfPublication41383d53-27b2-4b36-a8d4-ead2ae8fe63b
relation.isFunderOfPublication.latestForDiscovery289dce42-6a28-4892-b0a8-c70c46cbb185
relation.isPublisherOfPublicationa2759e3d-0d58-4e8a-9fcd-c6130ee333d1
relation.isPublisherOfPublication.latestForDiscoverya2759e3d-0d58-4e8a-9fcd-c6130ee333d1

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
MesenchymalStromalCellsDerived_2014.pdf
Size:
1.85 MB
Format:
Adobe Portable Document Format
Description: